Form IRANNOTICE DANAHER CORP /DE/
Tweet
Share
E-mailDANAHER CORPORATION
2200 Pennsylvania Avenue, N.W., Suite 800W
Washington, DC 20037
July 20, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Notice of Disclosure Filed in Exchange Act Quarterly Report Under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act | |||||||
Ladies and Gentlemen:
This filing is to provide notice to the U.S. Securities and Exchange Commission (the “SEC”) that Danaher Corporation’s Quarterly Report on Form 10-Q for the period ended July 1, 2022, which was filed with the SEC on July 20, 2022, contains information required to be disclosed by Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended. Such disclosure can be found under the heading “Item 5. Other Information—Disclosure Pursuant to Section 13(r) of the Exchange Act” in such Quarterly Report on Form 10-Q.
Respectfully submitted,
| DANAHER CORPORATION | ||||||||
| By: | /s/ James O’Reilly | |||||||
| Name: | James O’Reilly | |||||||
| Title: | Vice President, Deputy General Counsel and Secretary | |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Masimo gets FDA clearance for opioid respiratory risk detection
- iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant
- Albuquerque Regional Economic Alliance: State, City Back Spacecraft Manufacturer, Adding 152 Jobs
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
